Thomas Dibling
Impact in
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Genetics top 2%
- Genetic Associations and Epidemiology
- Genomic variations and chromosomal abnormalities
- Genetic Mapping and Diversity in Plants and Animals
Papers in
-
- SARS-CoV-2 and COVID-19 Research 5
- Genetics 3
- Genetic Associations and Epidemiology 3
- Genomic variations and chromosomal abnormalities 2
- Genetic Mapping and Diversity in Plants and Animals 2
- Partner nations
- United KingdomUnited StatesEstonia
In The Last Decade
Thomas Dibling
8 papers receiving 4k citations
Thomas Dibling's Hit Papers
Peers
Comparison fields: 5 of 127
- Infectious Diseases 2.2k
- Genetics 872
- Modeling and Simulation 106
- Molecular Biology 727
- Developmental Biology 13
Countries citing papers authored by Thomas Dibling
This map shows the geographic impact of Thomas Dibling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Dibling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Dibling more than expected).
Fields of papers citing papers by Thomas Dibling
This network shows the impact of papers produced by Thomas Dibling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Dibling. The network helps show where Thomas Dibling may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 evolution during treatment of chronic infection Hit paper breakdown → | 2021 | 814 |
| 2 | A Gene Map of the Human Genome Hit paper breakdown → | 1996 | 811 |
| 3 | 2020 | 756 | |
| 4 | 1998 | 549 | |
| 5 | Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies Hit paper breakdown → | 2021 | 530 |
| 6 | Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7 Hit paper breakdown → | 2021 | 325 |
| 7 | 2002 | 303 | |
| 8 | 2021 | 72 |
About Thomas Dibling
Thomas Dibling is a scholar working on Infectious Diseases, Genetics, Nuclear Energy and Engineering, Waste Management and Disposal and Organic Chemistry, having authored 8 papers that have together received 4.2k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (5 papers), Genetic Associations and Epidemiology (3 papers), Genomic variations and chromosomal abnormalities (2 papers) and Genetic Mapping and Diversity in Plants and Animals (2 papers). The work is most often cited by research in Infectious Diseases (2.2k citations), Genetics (872 citations), Modeling and Simulation (106 citations), Molecular Biology (727 citations) and Developmental Biology (13 citations). Thomas Dibling has collaborated with scholars based in United Kingdom, United States and Estonia. Their work appears in journals such as Nature, Science, Cell Reports and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.